Abstract:Abstract Introduction The generation of REM sleep involves mutually inhibitory interactions between brainstem aminergic and cholinergic neurons. The silencing of Locus Coeruleus and A5, noradrenergic neurons during REM sleep have been proposed to play a permissive role in the occurrence of REM sleep. Since noradrenergic SubCoeruleus (SubC) and A7 neurons have similar sleep-wake pattern of activity, we tested whether these neurons also participate in the regulation of the sleep-wake cycle in young and aging mice. Methods Fourteen adult DBH-cre mice (young 3-6 month-old, 4 males and 3 females; and aging 21-26 month-old, 5 males and 2 females) were bilaterally injected with excitatory M3-DREADD into A7/SubC pontine noradrenergic region. In two weeks, mice were implanted with EEG and neck EMG electrodes to record sleep-wake behavior. Four weeks following the DREADD injections, the mice were habituated to sleep-wake recording system. The EEG and neck EMG were collected from 9 am to 7 pm, and randomized CNO (0.3 mg/kg, i.p.) or saline injections were administered at 12 pm during experimental sessions. Sleep scoring was performed using SleepSign and sleep-wake states were manually defined in 5 s epochs. The duration of time spent in wakefulness, NREM, and REM sleep was calculated per hour for saline and CNO sessions. Pontine sections were processed for tyrosine hydroxylase (a marker for noradrenergic neurons) immunohistochemistry, and mCherry-positive (DREADD) A7/SubC neurons were counted. Results CNO tended to reduce total duration of REM sleep compared to saline injections within the first two hours after the injections in young (2.5 + 0.8 (SE) min vs. 4.6 + 0.8 min, n=7, p=0.078) and significantly decreased in old (2.5 + 0.6 min vs. 5.6 + 0.6 min, n=7, p< 0.001, paired t-tests) mice. The total duration of REM sleep was negatively correlated with the number of mCherry-positive, M3-expressing noradrenergic neurons. Conclusion The obtained results suggest that activation of A7/SubC noradrenergic neurons negatively affect REM sleep generation, which was more pronounced in older animals. These findings suggest a novel role for both SubC and A7 noradrenergic neurons in the regulation of REM sleep. Support (if any) NIIH/NIA R01AG065233

Adenosine A 2A Receptors in the Olfactory Bulb Suppress Rapid Eye Movement Sleep in Rodents

Adenosine A2A receptor neurons in the olfactory bulb mediate odor-guided behaviors in mice

Activation Of Adenosine A2a Receptors In The Olfactory Tubercle Promotes Sleep In Rodents

An Adenosine A2A Receptor Agonist Induces Sleep by Increasing GABA Release in the Tuberomammillary Nucleus to Inhibit Histaminergic Systems in Rats

Minireview: Sleep Regulation in Adenosine A 2A Receptor-Deficient Mice

Projections of nucleus accumbens adenosine A2A receptor neurons in the mouse brain and their implications in mediating sleep-wake regulation.

Striatal Adenosine A(2a) Receptor Neurons Control Active-Period Sleep Via Parvalbumin Neurons in External Globus Pallidus

Regulation of REM Sleep in Mice: the Role of Dopamine and Serotonin Function in the Basolateral Amygdala.

Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain

Rapid Eye Movement Sleep Deprivation Enhances Adenosine Receptor Activation and the CREB1/YAP1/c-Myc Axis to Alleviate Depressive-like Behaviors in Rats

A2A Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction

Roles of Adenosine and Its Receptors in Sleep-Wake Regulation

Adenosine A2A receptors and sleep

Activity-dependent Release of Adenosine Inhibits the Glutamatergic Synaptic Transmission and Plasticity in the Hypothalamic Hypocretin/orexin Neurons.

0228 Chemogenetic Activation of Noradrenergic A7 and SubCoeruleus Neurons Inhibits Generation of REM Sleep in Aging Mice

Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders

Adenosine A2A Receptor Deficiency Attenuates the Somnogenic Effect of Prostaglandin D2 in Mice

Acute administration of fluoxetine normalizes rapid eye movement sleep abnormality, but not depressive behaviors in olfactory bulbectomized rats.

OX2R-selective orexin agonism is sufficient to ameliorate narcoleptic symptoms, cataplexy and sleep/wakefulness fragmentation in mouse models

Ablation of Olfactory Bulb Glutamatergic Neurons Induces Depressive-Like Behaviors and Sleep Disturbances in Mice

Adenosine A1 Receptor-Mediated Attenuation of Reciprocal Dendro-Dendritic Inhibition in the Mouse Olfactory Bulb